ArticleProceedings of the National Academy of Sciences of the United States of America2019

Targeting CXCR4-induced desmoplasia to improve checkpoint inhibition in breast cancer.

George W SledgePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.